Use of imipramine for attention deficit disorder in a borderline patient.
A subcategory of patients with borderline personality disorder (BPD) who also meet criteria for attention deficit disorder (ADD) has recently been described. The present case involves a young man with BPD and ADD who failed to respond to methylphenidate but experienced a marked reversal of anxiety, explosiveness, restlessness, and affective lability when treated with imipramine. Tricyclics may prove to be helpful in borderlines who also meet criteria for ADD.
Satel
S
S
Department of Psychiatry, West Haven Veterans Administration Medical Center, Connecticut 06516.
Southwick
S
S
Denton
C
C
D000328:Adult; D001289:Attention Deficit Disorder with Hyperactivity / Q000150:complications / Q000188:drug therapy* / Q000523:psychology; D001883:Borderline Personality Disorder / Q000150:complications* / Q000188:drug therapy / Q000523:psychology; D006801:Humans; D007099:Imipramine / Q000627:therapeutic use*; D008297:Male; D008774:Methylphenidate / Q000627:therapeutic use; D010554:Personality Disorders / Q000150:complications*; D011569:Psychiatric Status Rating Scales
D008774:Methylphenidate; D007099:Imipramine